Clinical Trial Update: Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for topical intranasal tranexamic acid in epistaxis (TERMINATED; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Drugs mentioned

• tranexamic acid (topical intranasal formulation) (tranexamic acid)

Snippet

Sponsor: University of California, Davis | Conditions: Epistaxis | Phase 4 | Status: TERMINATED | Results posted: 2021-11-30